AutoICD API

Z79.811

Billable

Long term (current) use of aromatase inhibitors

Long term (current) use of aromatase inhibitors

Status

Billable / Specific

Block

Z77-Z99

Parent Code

Z79.81

Coding Notes

Inclusion Terms

Alternative clinical terms for this condition

  • Long term (current) use of anastrozole (Arimidex)
  • Long term (current) use of exemestane (Aromasin)
  • Long term (current) use of letrozole (Femara)

Includes

Conditions included under this code

  • long term (current) drug use for prophylactic purposes

Excludes 1

Codes that cannot be used together with this code (mutual exclusion)

  • hormone replacement therapy (Z79.890)

Excludes 2

Conditions not included here, but the patient may have both

  • drug abuse and dependence (F11-F19)
  • drug use complicating pregnancy, childbirth, and the puerperium (O99.32-)

Code First

The underlying condition must be sequenced before this code

  • , if applicable:
  • malignant neoplasm of breast (C50.-)
  • malignant neoplasm of prostate (C61)

Use Additional Code

Additional codes that should follow this code

  • code, if applicable, to identify:
  • estrogen receptor positive status (Z17.0)
  • family history of breast cancer (Z80.3)
  • genetic susceptibility to malignant neoplasm (cancer) (Z15.0-)
  • personal history of breast cancer (Z85.3)
  • personal history of prostate cancer (Z85.46)
  • postmenopausal status (Z78.0)

Code Also

A second code may be required; sequencing depends on circumstances

  • any follow-up examination (Z08-Z09)
  • any therapeutic drug level monitoring (Z51.81)

Also Known As / Clinical Terms

SNOMED CT

UMLS

Frequently Asked Questions

What is the ICD-10 code for long term (current) use of aromatase inhibitors?

The ICD-10-CM code for long term (current) use of aromatase inhibitors is Z79.811. The full clinical description is "Long term (current) use of aromatase inhibitors". Z79.811 is a billable/specific code that can be used on insurance claims and medical billing.

What does ICD-10 code Z79.811 mean?

ICD-10-CM code Z79.811 represents "Long term (current) use of aromatase inhibitors". It is classified under Chapter 22: Factors Influencing Health Status and Contact With Health Services and is a billable/specific code that can be used on a claim.

Is Z79.811 a billable code?

Yes, Z79.811 is a billable/specific ICD-10-CM code and can be used to indicate a diagnosis on a medical claim.

What chapter is Z79.811 in?

Z79.811 is in Chapter 22: Factors Influencing Health Status and Contact With Health Services (codes Z00-Z99).

What codes cannot be used with Z79.811?

Z79.811 has Excludes1 notes indicating codes that cannot be used together with it, including: hormone replacement therapy (Z79.890).

Are additional codes required with Z79.811?

Yes, when using Z79.811 you should also code: code, if applicable, to identify:; estrogen receptor positive status (Z17.0); family history of breast cancer (Z80.3); genetic susceptibility to malignant neoplasm (cancer) (Z15.0-); personal history of breast cancer (Z85.3); personal history of prostate cancer (Z85.46); postmenopausal status (Z78.0).

What SNOMED CT codes does Z79.811 map to?

Z79.811 maps to 1 SNOMED CT concept: 449351000124100. SNOMED CT is a clinical terminology used in electronic health records.

What are the UMLS CUIs for Z79.811?

Z79.811 is linked to 4 UMLS Concept Unique Identifiers: C2911194, C2911197, C2911195, C2911196. The UMLS (Unified Medical Language System) integrates multiple biomedical vocabularies maintained by the U.S. National Library of Medicine.

Automate ICD-10 Coding With AI

Send clinical text to the AutoICD API and get back structured ICD-10 codes with confidence scores. Integrates into any EHR or billing system in minutes.

Try FreeView API Docs

Includes SNOMED Clinical Terms® (SNOMED CT®) used by permission of SNOMED International. Includes content from the UMLS Metathesaurus, courtesy of the U.S. National Library of Medicine.